What's happening
This bill requires nursing homes to obtain informed written consent before administering antipsychotic medications to residents, with certain exceptions.
Why it matters
Strengthens patient autonomy and safeguards. By requiring informed written consent (with specific exceptions), the bill gives nursing home residents and their legal representatives more control over whether powerful antipsychotic drugs are administered—helping to prevent unnecessary or unwanted medication.
Improves transparency and understanding. The bill mandates that residents (or their lawful representatives) receive detailed information—including the reason for prescribing, potential benefits, risks, side effects, and alternative treatments—so they can make truly informed decisions.
Limits overuse and misuse of antipsychotics. By setting clear criteria for when consent is not needed (such as prior prescriptions, emergencies, certain diagnoses, or hospice care), the bill aims to curb routine or inappropriate use of antipsychotics, which have been linked to serious health risks in elderly populations.
Enhances oversight and family involvement. Documentation and notification requirements ensure that decisions are recorded and, when possible, communicated to family members, increasing accountability and allowing families to stay engaged in the care of their loved ones.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Nursing home residents and their lawful representatives
The bill would generally require informed written consent before starting antipsychotic medication, with specified exceptions and disclosures about risks, benefits, alternatives and the right to refuse or revoke consent.
Nursing homes and prescribing health care professionals
They would face consent and recordkeeping requirements, with emergency use without consent limited to the emergency and subject to documentation and notification rules.
Residents’ family members
Those whose notification requests are noted in the medical record would generally receive notice within 48 hours of an order when lawful, unless the resident specifically objects.
State health commissioner
The bill would authorize regulations to implement the nursing home antipsychotic medication requirements.
Headline styles
Require Consent for Psych Drugs
Plain English, a few words. Used as the page title.
Sponsors
30 Co-sponsors
- Nader Sayegh
- Phil Steck
- Jo Anne Simon
- Vivian Cook
- Deborah Glick
- Clyde Vanel
- Jen Lunsford
- Linda Rosenthal
- Harry B. Bronson
- Jaime R. Williams
- Rodneyse Bichotte Hermelyn
- Robert C. Carroll
- Charles Fall
- Emily Gallagher
- Phara Souffrant Forrest
- Catalina Cruz
- Albert A. Stirpe
- Sarah Clark
- William Colton
- Angelo Santabarbara
- Pamela J. Hunter
- Chantel Jackson
- Stefani Zinerman
- Anna Kelles
- Jonathan Jacobson
- Steven Otis
- Demond Meeks
- David Weprin
- Steven Raga
- Larinda Hooks
History
- Ordered to third reading cal.56
- Advanced to third reading cal.146
- Reported
- Reported referred to codes
- Print number 1461a
- Amend and recommit to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Limit Psych Meds in Nursing Homes
In Senate Committee · Aging · Sponsor Luis R. Sepúlveda
Full text
3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
1461--A
2025-2026 Regular Sessions
IN ASSEMBLY
January 9, 2025
Introduced by M. of A. PAULIN, SAYEGH, STECK, SIMON, COOK, GLICK, VANEL, LUNSFORD, ROSENTHAL, BRONSON, WILLIAMS, BICHOTTE HERMELYN, R. CARROLL, FALL, GALLAGHER, FORREST, CRUZ, STIRPE, CLARK, COLTON, SANTABARBARA, HUNTER, JACKSON, ZINERMAN, KELLES, JACOBSON, OTIS, MEEKS, WEPRIN, RAGA -- read once and referred to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the public health law, in relation to the use of psychotropic medications in nursing homes and adult care facilities
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 280-e to read as follows:
§ 280-e. Use of antipsychotic medications in nursing homes. 1. As used in this section:
(a) "lawful representative" means, where a resident lacks capacity to consent to health care, a person authorized to consent on behalf of the resident, including, but not limited to, a health care agent authorized by a health care proxy under article twenty-nine-C of this chapter or a surrogate under article twenty-nine-CC of this chapter; and
(b) "health care professional" means a health care professional, licensed, certified or authorized to practice under title eight of the education law, acting within such health care professional's lawful scope of practice, who has authority to order an antipsychotic medication.
2. (a) A nursing home or a health care professional shall obtain the informed written consent of the resident or the resident's lawful representative, before initiating the administration of an antipsychotic medication for a resident, provided that informed written consent shall not be required in the case of:
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD02250-06-5
(i) a resident who has been prescribed an antipsychotic medication prior to an admission or readmission to the nursing home;
(ii) a resident who has provided informed written consent within the last twelve months;
(iii) a resident receiving hospice care;
(iv) a resident of a nursing home's certified behavioral unit;
(v) a resident with a primary diagnosis of Huntington's disease; or
(vi) an emergency as defined in subdivision three of this section.
(b) Where a resident lacks capacity to consent to health care and lacks a lawful representative, a prescription under this section shall be subject to subdivision four of section twenty-nine hundred ninetyfour-g of this chapter as if the resident were an inpatient of a general hospital. To constitute informed written consent, the following disclosure shall be given to the resident or, where the resident lacks capacity to consent to health care, the resident's lawful representative, in a clear and explicit manner:
(i) the reason for the medication, including the nature and seriousness of the resident's illness, disorder or condition that the medication is intended to treat;
(ii) the anticipated benefit from the medication, and the dosage, and frequency;
(iii) the probability of side effects and significant risks of the medication, including the nature, degree, and duration of such effects and reasonably known risks;
(iv) the reasonable alternative treatments to the proposed medication and the reason that the prescribing health care professional prefers the proposed medication in this instance; and
(v) that the resident or lawful representative has the right to consent or refuse consent to use of the proposed medication, and that if such resident or lawful representative consents, such resident or lawful representative has the right to revoke such resident's or lawful representative's consent for any reason, at any time, including a description of how the consent shall be revoked.
(c) The health care professional shall document in the resident's medical record the date and time that the informed written consent disclosure was provided, and to whom and by whom it was provided.
(d) Where the resident's medical record notes that a family member has requested notification of medication orders or prescriptions, and such notification is otherwise lawful, the health care professional shall cause notice to be provided within forty-eight hours of the order under this section. Such notice shall not be provided if the resident specifically requests that the family member not be given notification.
3. A nursing home and a health care professional shall not be required to obtain consent under this section to issue an order for use of an antipsychotic medication for a resident in a nursing home where it is necessary in an emergency to protect against an immediate threat to the life, health or safety of the resident or another person. The medication must be the most appropriate available means of reducing that threat, with the least risk of harm considering the resident's condition or disorder. The order shall only apply, in the absence of consent, during the emergency. Where an order is made under this subdivision, the health care professional shall immediately record the use of the antipsychotic medication, the reason for the use, and the dosage, in the resident's medical record; and shall promptly notify the resident or the resident's lawful representative who would have had the authority to consent, and any family member required to be notified under this section and record such notifications in the resident's medical record.
4. This section does not increase the lawful scope of practice of any health care professional and does not diminish or impair any requirement for or regulation of consent to health care treatment.
5. The commissioner may make regulations to implement this section.
§ 2. This act shall take effect one year after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.